🇺🇸 FDA

Intelligence · Clinical Pipeline

Infectious disease · Phase I

Infectious disease programs at Phase I — ClinicalTrials.gov pipeline intelligence.

Programs
240

Quick answer

Infectious disease Phase I programs: NovaPharmaNews indexes 240 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 3 of 5

  1. EDP-721

    ENANTA PHARMACEUTICALS INC

    Chronic Hepatitis B Virus Infection

    phase 1 small molecule terminated

    1 trial

  2. EDP239

    ENANTA PHARMACEUTICALS INC

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  3. Electroporation-Mediated Plasmid DNA Vaccine Therapy

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis

    phase 1 mab active

    1 trial

  4. Emtricitabine

    United Therapeutics Europe Ltd

    HIV

    phase 1 small molecule completed

    1 trial

  5. Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 (HEB-PEP)

    Disc Medicine

    chronic Hepatitis B

    phase 1 other active

    1 trial

  6. Experimental Vaccine 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 1 mab completed

    1 trial

  7. Extracellular Vesicles from Mesenchymal Stem Cells

    Regeneron Ireland Designated Activity Company (DAC)

    COVID-19 Pneumonia

    phase 1 mab active

    1 trial

  8. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  9. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  10. Fecal Microbiota Transplantation

    Finch Therapeutics Group

    Enterobacteriaceae Infections

    phase 1 mab terminated

    1 trial

  11. Fluconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  12. Freethiadine tablets(part I)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  13. GC1102

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Hepatitis B

    phase 1 mab completed

    1 trial

  14. GLS-6150

    INOVIO PHARMACEUTICALS, INC.

    HCV Infection

    phase 1 mab completed

    1 trial

  15. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Non-Alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  16. GS-2829

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  17. Galidesivir

    Biocryst

    COVID-19

    phase 1 small molecule terminated

    1 trial

  18. Group 1: 10 ug FMP012 with 2 ug GLA-SE

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  19. HEC169584 capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  20. HEC74647

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  21. HEC74647PA capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    2 trials

  22. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  23. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  24. HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  25. HIV-1 C4-V3 Polyvalent Peptide Vaccine

    Praxis Precision Medicines

    HIV Infections

    phase 1 mab completed

    1 trial

  26. HIV-1 Peptide Vaccine, Microparticulate Monovalent

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  27. IMC-I109V Single Ascending Dose

    Immunocore Ireland Limited

    Hepatitis B, Chronic

    phase 1 small molecule terminated

    1 trial

  28. IMM-BCP-01

    United Therapeutics Europe Ltd

    SARS-CoV2 Infection

    phase 1 small molecule terminated

    1 trial

  29. INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  30. INO-1800

    INOVIO PHARMACEUTICALS, INC.

    Hepatitis B

    phase 1 mab completed

    1 trial

  31. ITX 5061

    United Therapeutics Europe Ltd

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  32. Inactivated Enterovirus Type 71 Vaccine

    Sinovac Research and Development Co.,

    Infection; Viral, Enterovirus

    phase 1 mab completed

    1 trial

  33. Influenza A/Texas/71/2017 (H3N2)

    United Therapeutics Europe Ltd

    Influenza Viral Infections

    phase 1 mab completed

    1 trial

  34. Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    phase 1 mab completed

    1 trial

  35. JNJ-53718678

    Janssen Cilag International NV

    Respiratory Syncytial Virus Infections

    phase 1 small molecule terminated

    1 trial

  36. JYEST Cell Injection Infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation

    phase 1 mab active

    1 trial

  37. Kangdaprevir Sodium Tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  38. Keverprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    phase 1 small molecule active

    1 trial

  39. LDT600 (Telbivudine)

    Novartis Pharmaceuticals

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial

  40. Lamivudine

    GlaxoSmithKline

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  41. Lanadelumab

    Takeda

    COVID-19 Pneumonia

    phase 1 small molecule terminated

    1 trial

  42. MGD020

    United Therapeutics Europe Ltd

    HIV (Human Immunodeficiency Virus)

    phase 1 small molecule active

    1 trial

  43. MK-4646 Single Ascending Dose Study and DDI in Healthy Participants

    Merck Sharp and Dohme

    HIV infection

    phase 1 other active

    1 trial

  44. MK-7480 Multiple Ascending Dose Study in Healthy Participants

    Merck Sharp and Dohme

    Non-alcoholic steatohepatitis

    phase 1 other active

    1 trial

  45. MMV390048 40 mg

    CNS Pharmaceuticals

    Malaria

    phase 1 small molecule completed

    1 trial

  46. MP-424 (Telaprevir)

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  47. MP-424(H), PEG-IFN-a-2b, RBV

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  48. MPT0B640

    INTENSITY THERAPEUTICS, INC.

    Covid19

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many infectious disease Phase I programs exist?

240 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.